Longitudinal <sup>1</sup>H NMR-Based Metabolomics in Saliva Unveils Signatures of Transition from Acute to Post-Acute Phase of SARS-CoV-2 Infection

COVID-19 can range from a mild to severe acute respiratory syndrome and also could result in multisystemic damage. Additionally, many people develop post-acute symptoms associated with immune and metabolic disturbances in response to viral infection, requiring longitudinal and multisystem studies to...

Full description

Saved in:
Bibliographic Details
Main Authors: Luiza Tomé Mendes, Marcos C. Gama-Almeida, Desirée Lopes Reis, Ana Carolina Pires e Silva, Rômulo Leão Silva Neris, Rafael Mello Galliez, Terezinha Marta Pereira Pinto Castiñeiras, on behalf of the UFRJ COVID-19 Working Group, Christian Ludwig, Ana Paula Valente, Gilson Costa dos Santos Junior, Tatiana El-Bacha, Iranaia Assunção-Miranda
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/16/11/1769
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850266545604788224
author Luiza Tomé Mendes
Marcos C. Gama-Almeida
Desirée Lopes Reis
Ana Carolina Pires e Silva
Rômulo Leão Silva Neris
Rafael Mello Galliez
Terezinha Marta Pereira Pinto Castiñeiras
on behalf of the UFRJ COVID-19 Working Group
Christian Ludwig
Ana Paula Valente
Gilson Costa dos Santos Junior
Tatiana El-Bacha
Iranaia Assunção-Miranda
author_facet Luiza Tomé Mendes
Marcos C. Gama-Almeida
Desirée Lopes Reis
Ana Carolina Pires e Silva
Rômulo Leão Silva Neris
Rafael Mello Galliez
Terezinha Marta Pereira Pinto Castiñeiras
on behalf of the UFRJ COVID-19 Working Group
Christian Ludwig
Ana Paula Valente
Gilson Costa dos Santos Junior
Tatiana El-Bacha
Iranaia Assunção-Miranda
author_sort Luiza Tomé Mendes
collection DOAJ
description COVID-19 can range from a mild to severe acute respiratory syndrome and also could result in multisystemic damage. Additionally, many people develop post-acute symptoms associated with immune and metabolic disturbances in response to viral infection, requiring longitudinal and multisystem studies to understand the complexity of COVID-19 pathophysiology. Here, we conducted a <sup>1</sup>H Nuclear Magnetic Resonance metabolomics in saliva of symptomatic subjects presenting mild and moderate respiratory symptoms to investigate prospective changes in the metabolism induced after acute-phase SARS-CoV-2 infection. Saliva from 119 donors presenting non-COVID and COVID-19 respiratory symptoms were evaluated in the acute phase (T1) and the post-acute phase (T2). We found two clusters of metabolite fluctuation in the COVID-19 group. Cluster 1, metabolites such as glucose, (CH<sub>3</sub>)<sub>3</sub> choline-related metabolites, 2-hydroxybutyrate, BCAA, and taurine increased in T2 relative to T1, and in cluster 2, acetate, creatine/creatinine, phenylalanine, histidine, and lysine decreased in T2 relative to T1. Metabolic fluctuations in the COVID-19 group were associated with overweight/obesity, vaccination status, higher viral load, and viral clearance of the respiratory tract. Our data unveil metabolic signatures associated with the transition to the post-acute phase of SARS-CoV-2 infection that may reflect tissue damage, inflammatory process, and activation of tissue repair cascade. Thus, they contribute to describing alterations in host metabolism that may be associated with prolonged symptoms of COVID-19.
format Article
id doaj-art-2f3dbf22af334380b7a3d7c44bb3fe41
institution OA Journals
issn 1999-4915
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj-art-2f3dbf22af334380b7a3d7c44bb3fe412025-08-20T01:54:08ZengMDPI AGViruses1999-49152024-11-011611176910.3390/v16111769Longitudinal <sup>1</sup>H NMR-Based Metabolomics in Saliva Unveils Signatures of Transition from Acute to Post-Acute Phase of SARS-CoV-2 InfectionLuiza Tomé Mendes0Marcos C. Gama-Almeida1Desirée Lopes Reis2Ana Carolina Pires e Silva3Rômulo Leão Silva Neris4Rafael Mello Galliez5Terezinha Marta Pereira Pinto Castiñeiras6on behalf of the UFRJ COVID-19 Working GroupChristian Ludwig7Ana Paula Valente8Gilson Costa dos Santos Junior9Tatiana El-Bacha10Iranaia Assunção-Miranda11LaRIV-Laboratory of Cellular Response to Viral Infections, Instituto de Microbiologia Paulo de Góes, Departamento de Virologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, BrazilLeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josué de Castro, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, BrazilLeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josué de Castro, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, BrazilLaRIV-Laboratory of Cellular Response to Viral Infections, Instituto de Microbiologia Paulo de Góes, Departamento de Virologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, BrazilLaRIV-Laboratory of Cellular Response to Viral Infections, Instituto de Microbiologia Paulo de Góes, Departamento de Virologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, BrazilNúcleo de Enfrentamento e Estudos de Doenças Infecciosas Emergentes e Reemergentes (NEEDIER), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-599, BrazilNúcleo de Enfrentamento e Estudos de Doenças Infecciosas Emergentes e Reemergentes (NEEDIER), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-599, BrazilDepartment of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UKNational Center for Nuclear Magnetic Resonance—Jiri Jonas, Institute of Medical Biochemistry, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, BrazilLabMet-Laboratory of Metabolomics, Instituto de Biologia Roberto Alcantara Gomes (IBRAG), Department of Genetics, State University of Rio de Janeiro, Rio de Janeiro 20551-030, BrazilLeBioME-Bioactives, Mitochondrial and Placental Metabolism Core, Institute of Nutrition Josué de Castro, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, BrazilLaRIV-Laboratory of Cellular Response to Viral Infections, Instituto de Microbiologia Paulo de Góes, Departamento de Virologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, BrazilCOVID-19 can range from a mild to severe acute respiratory syndrome and also could result in multisystemic damage. Additionally, many people develop post-acute symptoms associated with immune and metabolic disturbances in response to viral infection, requiring longitudinal and multisystem studies to understand the complexity of COVID-19 pathophysiology. Here, we conducted a <sup>1</sup>H Nuclear Magnetic Resonance metabolomics in saliva of symptomatic subjects presenting mild and moderate respiratory symptoms to investigate prospective changes in the metabolism induced after acute-phase SARS-CoV-2 infection. Saliva from 119 donors presenting non-COVID and COVID-19 respiratory symptoms were evaluated in the acute phase (T1) and the post-acute phase (T2). We found two clusters of metabolite fluctuation in the COVID-19 group. Cluster 1, metabolites such as glucose, (CH<sub>3</sub>)<sub>3</sub> choline-related metabolites, 2-hydroxybutyrate, BCAA, and taurine increased in T2 relative to T1, and in cluster 2, acetate, creatine/creatinine, phenylalanine, histidine, and lysine decreased in T2 relative to T1. Metabolic fluctuations in the COVID-19 group were associated with overweight/obesity, vaccination status, higher viral load, and viral clearance of the respiratory tract. Our data unveil metabolic signatures associated with the transition to the post-acute phase of SARS-CoV-2 infection that may reflect tissue damage, inflammatory process, and activation of tissue repair cascade. Thus, they contribute to describing alterations in host metabolism that may be associated with prolonged symptoms of COVID-19.https://www.mdpi.com/1999-4915/16/11/1769metabolomesalivaSARS-CoV-2 infectionlong COVIDmetabolic fluctuation
spellingShingle Luiza Tomé Mendes
Marcos C. Gama-Almeida
Desirée Lopes Reis
Ana Carolina Pires e Silva
Rômulo Leão Silva Neris
Rafael Mello Galliez
Terezinha Marta Pereira Pinto Castiñeiras
on behalf of the UFRJ COVID-19 Working Group
Christian Ludwig
Ana Paula Valente
Gilson Costa dos Santos Junior
Tatiana El-Bacha
Iranaia Assunção-Miranda
Longitudinal <sup>1</sup>H NMR-Based Metabolomics in Saliva Unveils Signatures of Transition from Acute to Post-Acute Phase of SARS-CoV-2 Infection
Viruses
metabolome
saliva
SARS-CoV-2 infection
long COVID
metabolic fluctuation
title Longitudinal <sup>1</sup>H NMR-Based Metabolomics in Saliva Unveils Signatures of Transition from Acute to Post-Acute Phase of SARS-CoV-2 Infection
title_full Longitudinal <sup>1</sup>H NMR-Based Metabolomics in Saliva Unveils Signatures of Transition from Acute to Post-Acute Phase of SARS-CoV-2 Infection
title_fullStr Longitudinal <sup>1</sup>H NMR-Based Metabolomics in Saliva Unveils Signatures of Transition from Acute to Post-Acute Phase of SARS-CoV-2 Infection
title_full_unstemmed Longitudinal <sup>1</sup>H NMR-Based Metabolomics in Saliva Unveils Signatures of Transition from Acute to Post-Acute Phase of SARS-CoV-2 Infection
title_short Longitudinal <sup>1</sup>H NMR-Based Metabolomics in Saliva Unveils Signatures of Transition from Acute to Post-Acute Phase of SARS-CoV-2 Infection
title_sort longitudinal sup 1 sup h nmr based metabolomics in saliva unveils signatures of transition from acute to post acute phase of sars cov 2 infection
topic metabolome
saliva
SARS-CoV-2 infection
long COVID
metabolic fluctuation
url https://www.mdpi.com/1999-4915/16/11/1769
work_keys_str_mv AT luizatomemendes longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT marcoscgamaalmeida longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT desireelopesreis longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT anacarolinapiresesilva longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT romuloleaosilvaneris longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT rafaelmellogalliez longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT terezinhamartapereirapintocastineiras longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT onbehalfoftheufrjcovid19workinggroup longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT christianludwig longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT anapaulavalente longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT gilsoncostadossantosjunior longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT tatianaelbacha longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection
AT iranaiaassuncaomiranda longitudinalsup1suphnmrbasedmetabolomicsinsalivaunveilssignaturesoftransitionfromacutetopostacutephaseofsarscov2infection